Erythema multiforme after use of topical dorzolamide.
Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide.
Munshi
Vineeta
V
Birmingham and Midland Eye Centre, Birmingham, United Kingdom. vineetamunshi@hotmail.com
Ahluwalia
Harpreet
H
D000287:Administration, Topical; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002387:Cataract Extraction; D003875:Drug Eruptions / Q000209:etiology; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide; D006854:Hydrocortisone